Your browser doesn't support javascript.
loading
Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma.
Nemoto, Yuki; Ishihara, Hiroki; Nakamura, Kazutaka; Tachibana, Hidekazu; Fukuda, Hironori; Yoshida, Kazuhiko; Kobayashi, Hirohito; Iizuka, Junpei; Shimmura, Hiroaki; Hashimoto, Yasunobu; Tanabe, Kazunari; Kondo, Tsunenori; Takagi, Toshio.
Afiliação
  • Nemoto Y; Department of Urology, Saiseikai Kawaguchi General Hospital, 5-11-5 Nishikawaguchi, Kawaguchi, Saitama, Japan.
  • Ishihara H; Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.
  • Nakamura K; Department of Urology, Tokyo Women's Medical University Medical Center East, 2-1-10 Nishiogu, Arakawa-ku, Tokyo, 116-8567, Japan. ishihara.hiroki@twmu.ac.jp.
  • Tachibana H; Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.
  • Fukuda H; Department of Urology, Tokiwakai Jyoban Hospital, 57 Kaminodai, Jyoban Kamiyunagayamachi, Iwaki, Fukushima, Japan.
  • Yoshida K; Department of Urology, Tokyo Women's Medical University Medical Center East, 2-1-10 Nishiogu, Arakawa-ku, Tokyo, 116-8567, Japan.
  • Kobayashi H; Department of Urology, Saiseikai Kurihashi Hospital, 714-6 Koemon, Kuki, Saitama, Japan.
  • Iizuka J; Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.
  • Shimmura H; Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.
  • Hashimoto Y; Department of Urology, Tokyo Women's Medical University Medical Center East, 2-1-10 Nishiogu, Arakawa-ku, Tokyo, 116-8567, Japan.
  • Tanabe K; Department of Urology, Tokyo Women's Medical University Medical Center East, 2-1-10 Nishiogu, Arakawa-ku, Tokyo, 116-8567, Japan.
  • Kondo T; Department of Urology, Tokiwakai Jyoban Hospital, 57 Kaminodai, Jyoban Kamiyunagayamachi, Iwaki, Fukushima, Japan.
  • Takagi T; Department of Urology, Saiseikai Kawaguchi General Hospital, 5-11-5 Nishikawaguchi, Kawaguchi, Saitama, Japan.
Int Urol Nephrol ; 54(1): 47-54, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34704214
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Protocolos de Quimioterapia Combinada Antineoplásica / Ipilimumab / Antineoplásicos Imunológicos / Nivolumabe / Inibidores de Checkpoint Imunológico / Neoplasias Renais Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Protocolos de Quimioterapia Combinada Antineoplásica / Ipilimumab / Antineoplásicos Imunológicos / Nivolumabe / Inibidores de Checkpoint Imunológico / Neoplasias Renais Idioma: En Ano de publicação: 2022 Tipo de documento: Article